knowledge/shared/creatinine-and-renal-function.md

# Creatinine and Renal Function

## Summary

Creatinine is generated from creatine and phosphocreatine, mainly in skeletal
muscle, and is eliminated predominantly through the kidneys. Its circulating
concentration reflects the balance between production, distribution, and
renal excretion. Creatinine is a conventional functional marker of glomerular
filtration, but it is an insensitive and nonspecific marker of early kidney
injury and is affected by muscle mass, hydration, assay method, and other
nonrenal factors.

## Scope

This resource covers general creatinine physiology and its interpretation as a
renal-function measurement, with emphasis on laboratory animals and
toxicology. It does not supply compound-specific effects or study-specific
reference values.

## Core knowledge

### Production and elimination

Creatine and phosphocreatine in muscle undergo spontaneous conversion to
creatinine. Production is related to the size and turnover of the creatine
pool, so animals with different muscle mass, age, sex, growth, or nutritional
state can have different baseline production.

Creatinine is freely filtered at the glomerulus and is not substantially
reabsorbed. Species-dependent tubular secretion means creatinine clearance is
not always identical to true glomerular filtration rate (GFR). If production
and distribution are stable, reduced filtration tends to increase circulating
creatinine.

### Clearance

Urinary creatinine clearance can be written as

\[
C_{\mathrm{Cr}} =
\frac{U_{\mathrm{Cr}} \times \dot{V}}
{P_{\mathrm{Cr}}},
\]

where \(U_{\mathrm{Cr}}\) is urine creatinine concentration, \(\dot{V}\) is
urine flow, and \(P_{\mathrm{Cr}}\) is plasma creatinine concentration.
Accurate timed urine collection and steady physiological conditions are
required. Tubular secretion and collection errors can make creatinine
clearance differ from measured GFR.

### Nonlinear relation to filtration

At steady state, plasma creatinine is approximately inversely related to GFR
when production is constant. The relationship is nonlinear: a substantial
loss of filtration can occur before creatinine clearly exceeds its expected
range, while a similar absolute concentration change can imply different
functional changes at different baselines.

After an acute change in filtration, creatinine takes time to reach a new
steady state. A measurement made during that transition does not satisfy the
simple steady-state inverse relationship.

### Functional marker versus injury marker

Creatinine describes excretory function rather than a specific molecular
lesion. Structural kidney injury may be present before filtration declines
enough to raise circulating creatinine. Conversely, dehydration, altered
hemodynamics, muscle injury, or assay interference can change creatinine
without primary structural renal injury.

In toxicologic interpretation, creatinine is therefore considered with urea
nitrogen, urine volume and composition, body weight and hydration, kidney
weight, histopathology, exposure, and more sensitive injury biomarkers when
available.

### Measurement considerations

The Jaffé reaction and enzymatic assays have different interference profiles.
Chromogens other than creatinine can affect colorimetric methods. Low
concentrations in small animals can approach method limitations, making
precision and calibration important.

Serum and plasma results can differ with method and sample handling. A change
should be interpreted relative to a method- and population-appropriate
baseline rather than a universal threshold.

## Conditions, limitations, and uncertainty

Creatinine production is not constant across all animals or physiological
states. A single circulating value cannot distinguish reduced filtration from
altered production, distribution, hydration, or assay interference. Normal
creatinine does not exclude kidney injury, especially when injury is early,
focal, or compensated. Cross-species differences in tubular handling and
baseline concentration limit direct transfer of clinical thresholds.

## References

1. Travlos GS, Morris RW, Elwell MR, Duke A, Rosenblum S, Thompson MB.
   Frequency and relationships of clinical chemistry and liver and kidney
   histopathology findings in 13-week toxicity studies in rats. *Toxicology*.
   1996;107(1):17–29. https://doi.org/10.1016/0300-483X(95)03197-N
2. Vaidya VS, Ozer JS, Dieterle F, et al. Kidney injury molecule-1 outperforms
   traditional biomarkers of kidney injury in preclinical biomarker
   qualification studies. *Nature Biotechnology*. 2010;28:478–485.
   https://doi.org/10.1038/nbt.1623
3. Clinical Pathology and Sample Collection in the Laboratory Rodent.
   https://pmc.ncbi.nlm.nih.gov/articles/PMC7110626/